{"id":2672,"date":"2026-07-10T11:16:19","date_gmt":"2026-07-10T08:16:19","guid":{"rendered":"https:\/\/arcon.org.ro\/servier\/"},"modified":"2026-07-10T11:18:50","modified_gmt":"2026-07-10T08:18:50","slug":"servier","status":"publish","type":"page","link":"https:\/\/arcon.org.ro\/en\/servier\/","title":{"rendered":"Servier"},"content":{"rendered":"\t\t<div data-elementor-type=\"wp-page\" data-elementor-id=\"2672\" class=\"elementor elementor-2672 elementor-2665\" data-elementor-post-type=\"page\">\n\t\t\t\t<div class=\"elementor-element elementor-element-648a882 e-flex e-con-boxed e-con e-parent\" data-id=\"648a882\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t<div class=\"elementor-element elementor-element-e210959 elementor-widget elementor-widget-image\" data-id=\"e210959\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"image.default\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<img fetchpriority=\"high\" decoding=\"async\" width=\"1024\" height=\"407\" src=\"https:\/\/arcon.org.ro\/wp-content\/uploads\/2026\/07\/Servier_Logo_Sign_RVB-1178x407-1-1024x407-1.png\" class=\"attachment-full size-full wp-image-2668\" alt=\"\" srcset=\"https:\/\/arcon.org.ro\/wp-content\/uploads\/2026\/07\/Servier_Logo_Sign_RVB-1178x407-1-1024x407-1.png 1024w, https:\/\/arcon.org.ro\/wp-content\/uploads\/2026\/07\/Servier_Logo_Sign_RVB-1178x407-1-1024x407-1-300x119.png 300w, https:\/\/arcon.org.ro\/wp-content\/uploads\/2026\/07\/Servier_Logo_Sign_RVB-1178x407-1-1024x407-1-768x305.png 768w, https:\/\/arcon.org.ro\/wp-content\/uploads\/2026\/07\/Servier_Logo_Sign_RVB-1178x407-1-1024x407-1-600x238.png 600w\" sizes=\"(max-width: 1024px) 100vw, 1024px\" \/>\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-39035a1 e-con-full e-flex e-con e-child\" data-id=\"39035a1\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t<div class=\"elementor-element elementor-element-520dec0 elementor-widget elementor-widget-text-editor\" data-id=\"520dec0\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t\t\t\t\t\t<p><span style=\"font-weight: 400;\">We are an independent international pharmaceutical company, innovating for and with patients. Being governed by a non-profit foundation gives us a patient-centric long-term vision; concretely, we prioritize long-term innovation for patients by reinvesting 100% of our profit in the development of the company. We are committed to advancing healthcare and creating a meaningful social impact, for a more sustainable world. As a result, patients are the ultimate beneficiaries of this uncommon and differentiated approach.\u00a0\u00a0<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Our Patient-Centric approach is driven by Innovation and digital solutions. We bring breakthrough innovation in hard-to-treat diseases and incremental innovation in chronic diseases. In Oncology, as of today:\u00a0 We use precision medicine, backed by &#8216;companion diagnostics&#8217;, to create breakthrough drugs, 70% of our R&amp;D budget being committed to oncology, focusing on gastro-intestinal cancers, In Neurology, in the medium-term, we will leverage our successes in Oncology, using the same precision medicine approach, which should also work particularly well in neurodegenerative diseases, a TA with no new drugs in over 50 years. In chronic cardiovascular diseases, we have a holistic portfolio approach, our single pill combinations being a game changer for therapeutic adherence: WHO estimates that if every patient with a chronic disease followed their treatment exactly, 200,000 deaths would be avoided each year in Europe.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">As a global player, we manage all our activities efficiently for the ultimate benefit of patients with significant assets in each therapy area and geography, creating value and making us a partner of choice. As a mid-size pharma company, we invest more resources in fewer projects, ensuring continuity and a long-term perspective in partnerships, promoting short decision-making circuits with accessible leaders and top managers, over 70 strategic alliances with other pharma companies, biotech companies and academics worldwide to accelerate innovation.<\/span><\/p>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"<p>We are an independent international pharmaceutical company, innovating for and with patients. Being governed by a non-profit foundation gives us a patient-centric long-term vision; concretely, we prioritize long-term innovation for patients by reinvesting 100% of our profit in the development of the company. We are committed to advancing healthcare and creating a meaningful social impact, [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"footnotes":""},"class_list":["post-2672","page","type-page","status-publish","hentry"],"acf":[],"_links":{"self":[{"href":"https:\/\/arcon.org.ro\/en\/wp-json\/wp\/v2\/pages\/2672","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/arcon.org.ro\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/arcon.org.ro\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/arcon.org.ro\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/arcon.org.ro\/en\/wp-json\/wp\/v2\/comments?post=2672"}],"version-history":[{"count":1,"href":"https:\/\/arcon.org.ro\/en\/wp-json\/wp\/v2\/pages\/2672\/revisions"}],"predecessor-version":[{"id":2673,"href":"https:\/\/arcon.org.ro\/en\/wp-json\/wp\/v2\/pages\/2672\/revisions\/2673"}],"wp:attachment":[{"href":"https:\/\/arcon.org.ro\/en\/wp-json\/wp\/v2\/media?parent=2672"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}